Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20663 | Sotuletinib HCl | 2222138-31-8 (HCl) | 98% Min. | |
| Sotuletinib, also known as BLZ945, is a potent and selective CSF-1R kinase inhibitor. | ||||
| 20662 | SKF-91488 HCl | 68941-21-9 | 98% Min. |  |
| SKF 91488 dihydrochloride is a homolog of dimaprit. | ||||
| 20650 | Sonrotoclax | 2383086-06-2 | 98% Min. |  |
| Sonrotoclax is an antineoplastic. | ||||
| 20639 | SOP1812 (QN-302) | 2546091-70-5 | ≧98.0% | _2546091-70-5.png) |
| QN-302 is a G-quadruplex (G4)-selective transcription inhibitor. | ||||
| 20633 | STX-478 | 2883540-92-7 | ≧98.0% |  |
| STX-478 is an allosteric PI3Kα inhibitor that selectively targets prevalent PI3Kα h | ||||
| 20604 | SEW2871 | 256414-75-2 | 98% Min. |  |
| SEW2871 is a S1P1 agonist (sphingosine-1-phosphate type 1 receptor agonist). SEW2871 | ||||
| 20576 | STX-721 | 2765525-82-2 | ≧98.0% |  |
| STX-721 is a next-generation, orally delivered therapy, designed with potential best- | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 20541 | (S)-1-BOC-2-METHYL-[1,4]DIAZEPANE | 194032-32-1 | 98% Min. | -1-BOC-2-METHYL-[1,4]DIAZEPANE_194032-32-1.png) |
| 20522 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol | 2921961-53-5 | 98% Min. | -5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol_2921961-53-5.png) |
| 20516 | (S)-3-AMINO-3-(4-CHLORO-PHENYL)-PROPIONIC ACID | 131690-60-3 | 98% Min. |  |
| 20454 | Samidorphan | 852626-89-2 | 98% Min. |  |
| Samidorphan, also known as ALKS-33 and RDC-0313, is an opioid modulator with μ-antag | ||||
| 20412 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester | 2170746-98-0 | 98% Min. | -pyrazino[1,2:1,5]pyrrolo[2,3-d]pyrimidine]-7(8H)-carboxylic_acid,_2-(methylthio)-6-oxo-5-[[(trifluoromethyl)sulfonyl]oxy]-,_1,1-dimethylethyl_ester_2170746-98-0.png) |
| 20396 | (S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine | 1980023-96-8 | 98% Min. | -1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethanamine_1980023-96-8.png) |
| G20378 | SB-4 agonist | 100874-08-6 | 98% Min. |  |
| SB 4 is a potent BMP4 agonist. | ||||
| 822222 | SEP-363856 HCl ( SEP-856 ) | 1310422-41-3 (HCl) | ≧98.0% | .png) |
| SEP-363856 is a novel trace amine receptor 1 (TAAR1) agonist with serotonin 5-HT1A ac | ||||
| 1711224 | SRI-37330 free base | 2322245-42-9 (free base) | 98% Min. | .jpg) |
| SRI-37330 is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
| 20368 | SHMT-IN-2 | 2102681-49-0 | ≧98.0% |  |
| SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting | ||||
| L20355 | SRI-011381 | 1629138-41-5 | 98% Min. |  |
| SRI-011381 is an agonist of the TGF-beta signaling pathway for treatment of Alzheimer | ||||
| L20353 | SJ-172550 | 431979-47-4 | 98% Min. |  |
| SJ-172550, also known as MDMX Inhibitor II, is an inhibitor of MDMX that disrupts MDM | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| L20338 | Stafia-1 | 2582757-90-0 | 98% Min. |  |
| 20321 | STM2457 | 2499663-01-1 | 98% Min. |  |
| STM2457 is a highly potent and selective first-in-class catalytic inhibitor of METTL3 | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
| 21252 | SM-102 | 2089251-47-6 | ≧98.0% |  |
| SM-102 is an ionizable amino lipid that has been used in combination with other lipid | ||||
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib, also known as PK-10571 and GB002, is a Novel Inhaled Pdgfr Kinase Inhibi | ||||
| 21232 | Sonidegib (LDE-225) | 956697-53-3 | 98% Min. | _956697-53-3.png) |
| Sonidegib, also known as, erismodegib, LDE225, NVP-LDE225, is an orally bioavailable | ||||
| 21230 | SB-366791 | 472981-92-3 | 98% Min. |  |
| SB-366791 is a potent and selective TRPV1 antagonist. SB-366791 inhibits glutamatergi | ||||
| 21229 | Scriptaid | 287383-59-9 | 98% Min. |  |
| Scriptaid, also known as GCK 1026, is a HDAC inhibitor. Scriptaid protects against tr | ||||